Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992
The Spectrum of Neurol Dis Assoc with Antiphospholipid Antibd, Lupus Anticoag & Anticardiolipin Antibd
Arch Neurol 44:876-883, Levin,S.R.&Welch,K.M.A., 1987
COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
Zika Virus Associated with Microcephaly
NEJM 374: DOI:10.1056/NEJMoa1600651, Mlakar, J.,et al, 2016
Neurological Immune-Related Adverse Events of Ipilimumab
Pract Neurol 13:278-280, Bot, I.,et al, 2013
A Poliomyelitis-like Syndrome from West Nile Virus Infection
NEJM 347:1279-1280, Leis,A.A., et al, 2002
The Outbreak of West Nile Virus Infection in the New York City Area in 1999
NEJM 344:1807-1814,1858, Nash,D.,et al, 2001
Eosinophilia-Myalgia Syndrome-New Mexico
JAMA 262:3116, Belvins,W.L.,et al, 1989
Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987
Human-To-Human Transmission of Rabies Virus by Corneal Transplant
NEJM 300:603-604, Houff,S.A.,et al, 1979
Polyradiculoneuropathy in Addison's Disease:Case report & review of literature
Neurol 27:494, Abbas,D.H.,et al, 1977
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Central Nervous System Manifestations of Periarteritis Nodosa
Neurol 15:114, Ford,R.G.,et al, 1965
Unpacking the CNS Manifestations of Epstein-Barr Virus:An Imaging Perspective
AJNR 44:1002-1008, Soni,N.,et al, 2023
An 8-Year-Old with Acute Onset Ataxia
Neurol 99:305-310, McLaren, J.R.,et al, 2022
Neurologic Complications of Coronavirus Infections
Neurol 94:809-810, Nath, A., 2020
A case of COVID-19-associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome
Neurol 95:978-983, Liberatore, G.,et al, 2020
Mechanisms, Causes, and Effects of Hypercapnia
UptoDate Dec, Feller-Kopman, D.J. & Schwartzstein, R.M., 2016
Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016
Neurologic Complications in Dengue Virus Infection
Neurol 83:1601-1609,1590, Sahu, R.,et al, 2014
Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Mycoplasma Pneumoniae
Adams & Victors Principles of Neurology, Chp 32, pg 708, Ropper, A.H.,et al, 2014
Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012
Epstein-Barr Virus Infections of the Nervous System
www.medlink.com, Nov, Amlie-Lefond,C., 2011
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Pediatric Encephalitis: What Is the Role of Mycoplasma Pneumoniae
Pediatrics 120:305-313, Christie,L.J., et al, 2007
Poliomyelitis Due to West Nile Virus
NEJM 347:1280-1281, Glass,J.D.,et al, 2002
Mycoplasma Pneumoniae Encephalitis in Childhood
J Microbiol Immunol Infect 35:173-178, Lin,W.-C., et al, 2002
Nonpoliovirus Poliomyelitis Simulating Guillain-Barre Syndrome
Arch Neurol 58:1460-1464, Gorson,K.C.&Ropper,A.H., 2001
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999
Alcohol-Related Acute Axonal Polyneuropathy,A Differential Diagnosis of Guillain-Barre Syndrome
Arch Neurol 55:1329-1334, Wohrle,J.C.,et al, 1998
The Spectrum of Antecedent Infections in Guillain-Barre Syndrome
Neurol 51:1110-1115, Jacobs,B.C.,et al, 1998
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997
Idiopathic Dysautonomia Treated with Intravenous Gammaglobulin
Lancet 347:28-29, Heafield,M.T.E.,et al, 1996
Cytomegalovirus Infection and Guillain-Barre Syndrome:The Clinical, Electrophysiologic, and Prognostic Features
Neurol 47:668-673, Visser,L.H.,et al, 1996
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Lyme Neuroborreliosis
Ann Neurol 37:691-702, Garcia-Monco,J.C.&Benach,J.L., 1995
Acute Neuromuscular Respiratory Paralysis
JNNP 56:334-343, Hughes,R.A.C.&Bihari,D., 1993
Clinical Signs in Severe Guillain-Barre Syndrome: Analysis of 63 Patients
J Neurol Sci 104:143-150, De Jager, A.E.J.,et al, 1991
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
Clinicopath Conf
Hodgkin's Disease and Acute Paraneoplastic Sensory Ganglionitis, NEJM 322:531-5431990., , 1990
Ganciclovir in the Treatment of Progressive AIDS-Related Polyradiculopathy
Neurol 40:569-574, Miller,R.G.,et al, 1990
Recurrent Guillan-Barre Syndrome After Multiple Exposures to Cytomegalovirus
Am J Med 87:339-341, Donaghy,M.,et al, 1989
Neuromuscular Diseases Associated with Human Immunodeficiency Virus Infection
Ann Neurol 23:S38-S48, Dalakas,M.C.&Pezeshkpour,G.H., 1988